Ohashi K | Third Department Of Internal Medicine Hamamatsu University School Of Medicine
スポンサーリンク
概要
- Ohashi Kazuyoshiの詳細を見る
- 同名の論文著者
- Third Department Of Internal Medicine Hamamatsu University School Of Medicineの論文著者
関連著者
-
Osaki K
Department Of Pathology Kurume University School Of Medicine
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
三木 義男
癌研ゲノムセンター
-
Watanabe Hiroshi
Department of Cardiology, Niigata City General Hospital
-
Satoh Hiroshi
Department of Pharmacy, Niigata University Medical and Dental Hospital
-
Tobinai K
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Osaki Koichi
九州厚生年金病院
-
Kato T
Department Of Gastroenterological Surgery Aichi Cancer Center Hospital
-
渋谷 博孝
福山大学
-
Tsuboi Naoya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
OHASHI Kazuteru
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
AKIYAMA Hideki
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
SAKAMAKI Hisashi
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
下田 博司
森下仁丹株式会社商品開発本部
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
Katayama Y
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Seto M
Department Of Hematology And Chemotherapy
-
Seto Masao
愛知県がんセンター研究所 分子腫瘍学部
-
Seto Masao
東京大学医学部附属病院 無菌治療部
-
TAWARA Masayuki
Nagasaki CML Study Group
-
Miyazaki Yoshitsugu
長崎大学 第二内科
-
Tobinai Kensei
国立がんセンター中央病院 血液内科グループ
-
Nakamura Shigeo
群馬県立がんセンター 病理検査
-
OHNO Ryuzo
Aichi Cancer Center
-
OHSHIMA Koichi
Department of Pathology, Kurume University School of Medicine
-
SUGIYAMA Haruo
Departments of Clinical Laboratory Science
-
Nakamura S
Department Of Pathology Nagoya University School Of Medicine
-
坂本 弘明
Department of Internal Medicine II, Fukushima Medical University, School of Medicine
-
谷脇 雅文
高知工科大学工学部
-
MORI Shinichiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
OGURA Michinori
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
KIKUCHI Masahiro
Department of Pathology, School of Medicine, Fukuoka University
-
斉藤 広信
福島県立医科大学 医学部内科学第二講座
-
Ando Kiyoshi
Division of Hematology and Oncology, Tokai University School of Medicine
-
シマンジュンタク パルトムアン
大阪大学薬学部
-
YOSHINO Tadashi
Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutica
-
MIYAZAKI Yasushi
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
YAGASAKI Fumiharu
Department of Hematology, Saitama Medical University Hospital
-
WATANABE Takashi
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
TOBINAI Kensei
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
Hirose Shinichi
Department of Pediatrics, Faculty of Medicine, Fukuoka University
-
NAKAMURA Shigeo
Department of Clinical Pathology, Aichi Cancer Center Hospital
-
OHNISHI Kazunori
Department of Internal Medicine, Hamamatsu University School of Medicine
-
Nakamura Shigeo
国立がんセンター中央病院 血液内科
-
岡田 昌也
兵庫医科大学総合内科学血液・腫瘍科
-
OKUMURA Hirokazu
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
山田 幸子
日本大学医学部生化学分野
-
永井 正
自治医科大学内科学講座血液学部門
-
ITOH Kuniaki
Division of Oncology and Hematology, National Cancer Center Hospital East
-
Horlad Hasita
Department Of Gastroenterological Surgery Graduate School Of Medical Sciences Kumamoto University
-
CHOU Takaaki
Department of Internal Medicine, Niigata Cancer Center Hospital
-
SHIMOYAMA Masanori
National Cancer Center Hospital
-
永井 正
自治医科大学 内科学講座血液学部門
-
Kojima M
Department Of Anatomic And Diagnostic Pathology Dokkyo University School Of Medicine
-
JINNAI Itsuro
Nagasaki CML Study Group
-
OHYASHIKI Kazuma
First Department of Internal Medicine (Division of Hematology), Tokyo Medical University
-
Shimoda Kazuya
九州大学 医学部病態情報学
-
KAKIHANA Kazuhiko
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
YAMAGUCHI Toshikazu
Development of Clinical Genomics, BML
-
MIYAWAKI Shuichi
Division of Hematology, Saiseikai Maebashi Hospital
-
KIYOI Hitoshi
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
NAGAI Tadashi
Division of Hematology, Jichi Medical University
-
TAKEUCHI Jin
Department of Hematology and Rheumatology, Nihon University School of Medicine
-
UIKE Naokuni
Department of Hematology, National Kyushu Cancer Center
-
SUGITA Yasuo
Department of Pathology and Biodefense, Saga University, Faculty of Medicine
-
Takeya Motohiro
Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University
-
NAKAO Shinji
Department of Cellular Transplantation Biology, Graduate School of Medical Sciences, Kanazawa Univer
-
MORISHIMA Yasuo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
HOTTA Tomomitsu
Department of Hematology and Oncology, Tokai University School of Medicine
-
YOSHIDA Shiro
Department of Obstetrics, Center for Perinatal Medicine
-
Tobinai Kensei
東海大学 医学部
-
Yoshida Shiro
Department Of Obstetrics Center For Perinatal Medicine
-
Sadahira Yoshito
Department Of Pathology School Of Medicine Kurume University
-
KINOSHITA Tomohiro
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
山田 静雄
静岡県立大学薬学部
-
山田 静雄
横浜薬科大学 薬理学研究室
-
Minami H
Medical Oncology Department Of Medicine Kobe University Hospital And Graduate School Of Medicine
-
Minami Hironobu
神戸大学 医学研究科腫瘍内科学
-
SUZUKI Ritsuro
Department of HSCT Data Management, Nagoya University Hospital
-
KOJIMA Masaru
Department of Anatomic and Diagnostic Pathology, Dokkyo University School of Medicine
-
USUI Noriko
Department of Medicine, Division of Hematology and Oncology, Jikei University School of Medicine
-
OKAMOTO Shinichiro
Division of Hematology, Department of Medicine, Keio University School of Medicine
-
KANDA Yoshinobu
Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo
-
Tomonari Akira
東京大学医科学研究所附属病院 血液腫瘍内科
-
野中 源一郎
九州大学薬学部
-
YAMAMOTO Masahide
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
TADOKORO Kenichi
Development of Clinical Genomics, BML
-
MORITA Yasuyoshi
Department of Hematology, Kinki University School of Medicine
-
KANAMARU Akihisa
Department of Hematology, Kinki University School of Medicine
-
IMANISHI Daisuke
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
TANIMOTO Mitsune
Blood Transfusion Division, Department of Internal Medicine II, Okayama University Graduate School o
-
KURIYAMA Kazutaka
Blood Immunology Laboratory, School of Health Sciences, Faculty of Medicine and University Hospital,
-
KOBAYASHI Toru
Department of Hematopoietic Pathobiology and Medical Oncology, Mie University Graduate School of Med
-
IMOTO Shion
Hyogo Prefectural Red Cross Blood Center
-
OHNISHI Kazunori
Third Department of Internal Medicine, Hamamatsu University School of Medicine
-
OHTAKE Shigeki
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
MATSUDA Shin
Center for Hematopoietic Disorders, Ohta Nishinouchi Hospital, The Ohta Foundation
-
KISHIMOTO Yuji
The First Department of Internal Medicine, Kansai Medical University
-
OKADA Masaya
Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine
-
TAKAHASHI Masatomo
Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School
-
HANDA Hiroshi
Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine
-
KAGEYAMA Shinichi
Department of Hematology and Oncology, Mie University Graduate School of Medicine
-
ASOU Norio
Department of Hematology, Kumamoto University School of Medicine
-
MAEDA Yasuhiro
Department of Hematology, Kinki University School of Medicine
-
OHNISHI Kazunori
Oncology Center, Hamamatsu University School of Medicine
-
ETO Tetsuya
Department of Hematology, Hamanomachi Hospital
-
MORIUCHI Yukiyoshi
Department of Hematology, Sasebo City General Hospital
-
SUZUMIYA Junji
Department of Internal Medicine, Fukuoka University Chikushi Hospital
-
EMI Nobuhiko
Department of Hematology, Fujita Health University
-
Tamura Kazuo
First Department of Internal Medicine, Fukuoka University
-
Iida Hiroatsu
Department of Hematology, Meitetsu Hospital
-
ISHIKAWA Yuichi
Department of Pathology, the Cancer Institute of JFCR
-
中尾 眞二
Cellular Transplantation Biology Kanazawa University Graduate School Of Medical Science
-
Miyazawa Keisuke
Department of Biochemistry and Intractable Immune System Disease Research Center, Tokyo Medical Univ
-
吉川 秀樹
大阪大学大学院医学系研究科器官制御外科学(整形外科)
-
馬場 秀夫
国立病院機構熊本南病院 外科
-
YOSHIKAWA Hideki
Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine
-
Mizuno Kyoichi
Division Of Cardiology Hepatology Geriatrics And Integrated Medicine Department Of Internal Medicine
-
Matsuda Koichi
Department Of Internal Medicine Tokyo Metropolitan Komagome Hospital
-
Mizuno Kyoichi
日本医科大学 内科学
-
SUZUKI Yoshihiko
Suzuki clinic
-
Sakashita Naomi
Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University
-
梶原 哲郎
Tochigi Cancer Center Hospital
-
梶原 哲郎
東京女子医科大学第二病院外科
-
MIYAMURA Koichi
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
Yoshida S
Chiba University
-
MATSUNO Yoshihiro
Department of Surgical Pathology, Hokkaido University Hospital
-
YOKOYAMA Hiroki
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
KAGAMI Yoshitoyo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
KOHGO YUTAKA
Department of Medicine, Division of Gastroenterology and Hematology/Oncology, Asahikawa Medical Coll
-
Nakamura Yusuke
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of T
-
Saito Y
Division Of Cardiovascular Medicine Kumamoto University Graduate School Of Medical Sciences
-
BABA Hideo
Department of Surgery, Kyushu Cancer Center
-
MIYAZAKI Koji
Departments of Surgery, Saga Medical School
-
Saito Yoshiro
国立医薬品食品衛生研究所
-
Inoue Masahiro
Department of Oral Implantology, Osaka Dental University
-
TSURUTA Kazuto
the Department of Laboratory Midicine
-
Totsune Kazuhito
東北大学 臨床薬学
-
Tokunaga Katsushi
Department Of Clinical Pharmacology And Therapeutics Tohoku University Graduate School Of Pharmaceut
-
山田 静雄
静岡県立大学・薬学部・医療薬学大講座薬物動態学分野
-
MATSUDA Koichi
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, the University
-
KATAGIRI Toyomasa
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, the University
-
Nakamura Yusuke
東京大学医科学研究所ヒトゲノム解析センター ゲノムシークエンス解析分野
-
Katagiri Toyomasa
京都大学 医学部外科学
-
Katagiri T
Univ. Tokyo Tokyo Jpn
-
Katagiri Toyomasa
Laboratory Of Molecular Biosignal Research Center Kobe University School Of Medicine
-
Yokoyama Reiko
Pharmacy Division Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospital
-
KOHNO Akio
Department of Hematology and Oncology JA Aichi Konan Kosei Hospital
-
NAJIMA Yuho
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
KAWAMURA Machiko
Pediatrics Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
ONOZUKA Yuji
Development of Clinical Genomics
-
UEDA Yasunori
Department of Pediatrics and Department of Hematology/Oncology, Kurashiki Central Hospital
-
Nagane Y
Sanai Hospital Iwate Jpn
-
Nagane Yutaka
東京大学医科学研究所ヒトゲノム解析センター
-
Nagane Yutaka
Department Of Urology Sanai Hospital
-
YOSHIMURA Kenichi
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
OKAMOTO Rumiko
Department of Chemotherapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospi
-
HIRANO Masami
Department of Hematology, Fujita Health University School of Medicine
-
ASAOKU Hideki
Clinical Laboratory, Hiroshima Red Cross Hospital, Atomic-Bomb Survivors Hospital
-
KUROSAWA Mitsutoshi
Department of Hematology, National Hospital Organization, Hokkaido Cancer Center
-
MAEDA Yoshiharu
Department of Chemotherapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospi
-
OMACHI Ken
Department of Hematology and Oncology, Tokai University School of Medicine
-
KASAI Masaharu
Department of Hematology, Sapporo Hokuyu Hospital
-
TAKAYAMA Nobuyuki
Second Department of Internal Medicine, Kyorin University
-
KABA Harumi
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
YAMAMOTO Seiichiro
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
FUKUDA Haruhiko
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
HOTTA Tomomitsu
National Hospital Organization, Nagoya Medical Center
-
Baba Hideo
熊本大学 医学薬学研究部消化器外科学
-
HANAMURA Akitoshi
Department of Hematology, Gifu Prefectural Tajimi Hospital
-
Koike Minako
東京女子医科大学附属腎臓病総合医療センター
-
Kajiwara Tetsuro
Tochigi Cancer Center Hospital
-
Kodama Tetsuro
栃木県立がんセンター研究所 がん遺伝子研究室
-
Kasugai Tsutomu
東京大学医科学研究所ヒトゲノム解析センター 分子医学
-
Yamaguchi Yuko
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
HIGASHIHARA Masaaki
Department of Hematology, Kitasato University School of Medicine
-
Miura S
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
TANIGUCHI Shuichi
Department of Hematology, Toranomon Hospital
-
Aoki Sadao
Division of Hematology and Cardiology, Graduate School of Medical and Dental Science, Niigata Univer
-
IWANAGA Masako
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
KURIYAMA Kazutaka
Nagasaki CML Study Group
-
木村 良平
静岡県立大学薬学部薬剤学・coe21
-
木村 良平
東北大学大学院工学研究科
-
木村 良平
静岡県立大学薬学部 薬剤学教室
-
Kimura R
School Of Pharmaceutical Sciences And Coe21 University Of Shizuoka Medicine
-
KATO Junji
Sapporo Medical University Hospital
-
SAKAMAKI Hisashi
Department of Hematology, Tokyo Metropolitan Komagome Hospital
-
KASAI Masanobu
Department of Hematology, Nagoya Daini Red Cross Hospital
-
Seino Yoshihiko
Department Of Internal Medicine Cardiovascular Center Nippon Medical School Chiba-hokusoh Hospital
-
OHTSU Tomoko
Amgen Limited
-
OHTSU Tomoko
Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
-
KOBAYASHI Takeshi
Department of Electrical Engineering, Faculty of Engineering Science, Osaka University
-
Nakamura Yosikazu
千代田区千代田保健所
-
FUJITA Hiroyuki
Department of Rheumatology/Hematology/Infectious Disease, Yokohama City University Hospital
-
KOJIMA Seiji
Department of Pediatrics, Nagoya University Graduate School of Medicine
-
TAKAHASHI Naoto
Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine
-
SAWADA Kenichi
Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine
著作論文
- Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCR
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Molecular monitoring of BAALC expression in patients with CD34-positive acute leukemia
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- PJ-788 Calmodulin Regulates Mitochondrial Ca2+ Homeostasis by Activating Mitochondrial Na+/Ca2+ Exchanger(PJ132,Heart Failure, Basic (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- PJ-062 Evaluation of Low- Non- Enhancement Myocardium on Cardiac Multi-Detector Row Computed Tomography (MDCT) in the Diagnosis of Myocardial Viability(PJ011,CT/MRI (Myocardium) 4 (I),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Jap
- OE-133 Thiol-Mediated Responses Contribute to the Biphasic Effects of Nitric Oxide (NO) on Mitochondrial Permeability Transition Pore(OE23,Heart Failure (Pathophysiology) (M),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese C
- FRS-065 Regulation of Mitochondrial Permeability Transition Pore by Glycogen Synthase Kinase 3β (GSK3β) is Related to Mitochondria-bound Hexokinase Activity(FRS13,Novel Molecular Mechanisms of Heart Failure 2 (M),Featured Research Session (English),The 73
- The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis
- PJ-145 Intravenous Glutathione(GSH), a Novel Prophylaxis against Contrast-induced Nephropathy(CIN)(Kidney/Renal circulation(05)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-115 Protein phosphatase inhibitor 1 (l-1) augments a protein kinase A-dependent increase in SR Ca2+ loading without changing Ca2+ spark(Heart failure, basic(05)(M),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation
- PE-217 Different Effects of Palmitoyl-L-carnitine and Palmitoyl-CoA on Mitochondrial Function in Rat Myocytes(Metabolism/Biochemistry/Energetics(02)(M),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-094 Local Control of Mitochondrial Membrane Potential and Permeability Transition Pore by Calcium and Calmodulin in Rat Ventricular Myocytes(Heart failure, basic(02)(M),Oral Presentation(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circ
- OJ-051 Dual Effects of Nitric Oxide on Mitochondrial Permeabillity Transition in Rat Ventricular Myocytes(Myocarditis, basic/clinical(M),Oral Presentation(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- Excessive nitric oxide production and cardiac dysfunction in patients with chronic renal failure
- A variant transcript, e1a3, of the minor BCR-ABL fusion gene in acute lymphoblastic leukemia : case report and review of the literature
- PJ-566 Influence of CYP2C9 Genotype on Pharmacokinetics and Pharmacodynamics of Benzbromarone(Cardiovascular pharmacology, basic/clinical-6, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-561 Antiproliferative Effect of Cyclic AMP on Human Umbilical Vein Endothelial Cells through TGF-beta Inducing p21(Cip1/Waf1) Expression(Cardiovascular pharmacology, basic/clinical-6, The 71st Annual Scientific Meeting of the Japanese Circulation Socie
- Evaluation of right and left ventricular function by quantitative blood-pool SPECT (QBS) : Comparison with conventional methods and quantitative gated SPECT (QGS)
- PJ-337 The significance of Delayed Enhancement MRI to Evaluate Global and Local Left Ventricular Wall Function in Hypertrophic Cardiomyopathy(Cardiomyopathy, basic/clinical-5 (M) PJ57,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meetin
- OJ-002 Influence of Genetic Polymorphisms of OATP-C on Cholesterol Lowering Effect of Pravastatin(Cardiovascular pharmacology, basic/clinical-2 (H) OJ1,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation
- 4 Inhibition of Type-5 Phosphodiesterase : Promising Therapy for Pulmonary Hypertension(Which drug is useful for the treatment of pulmonary hypertension?,Topic 4 (TP4) (M),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- Long-Term Survival in Patients with Pulmonary Hypertension Treated with a Type 5 Phosphodiesterase Inhibitor Sildenafil(Pulmonary Circulation 2 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- OE-271 Pharmacokinetic and pharmacodynamic interactions between simvastatin and diltiazem in patients with hypercholesterolaemia and hypertension(Cardiovascular Pharmacology, Basic/Clinical 1 (H) : OE34)(Oral Presentation (English))
- Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Leukemic infiltration of the lung following allogeneic hematopoietic stem cell transplantation
- OE-243 Regenerated Endothelium Produces not Vasodilative but Vasoconstrictive Prostanoid(s) via Cyclooxygenase-dependent Pathway(Chronic coronary heart disease/Remodeling(01)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japane
- Inhibition of Type 5 Phosphodiesterase : Promising Therapy for Pulmonary Hypertension
- A potential role of sildenafil in the management of pulmonary hypertension
- A novel nonpeptide bradykinin receptor agonist in the regulation of endothelial calcium signaling and coronary artery tone
- Mikulicz's disease with severe thrombocytopenia following autologous stem cell transplantation in a multiple myeloma patient
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Oncogene Associated cDNA Microarray Analysis Shows PRAME Gene Expression is a Marker for Response to Anthracycline Containing Chemotherapy in Patients with Diffuse Large B-cell Lymphoma
- Estimation of the relationship between caspase-3 expression and clinical outcome of Burkitt's and Burkitt-like lymphoma
- High-grade mature B-cell lymphoma with Burkitt-like morphology : Results of a clinicopathological study of 72 Japanese patients
- Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase
- A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease
- A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade^【○!R】, ICL670) in patients with transfusion-dependent anemias and iron-overload : a Phase I study in Japan
- Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusion
- Cystatin C level as a marker of renal function in allogeneic hematopoietic stem cell transplantation
- Arrhythmogenic Effects of Arsenic Trioxide in Patients With Acute Promyelocytic Leukemia and an Electrophysiological Study in Isolated Guinea Pig Papillary Muscles
- Transformation of Cinchona Alkaloids into 1-N-Oxide Derivatives by Endophytic Xylaria sp. Isolated from Cinchona pubescens
- Improvement in the Histopathology of Hearts from Cardiomyopathic BIO TO-2 Hamsters Following Long-Term Administration of Amlodipine and Cilnidipine
- Preparation and Cancer Cell Invasion Inhibitory Effects of C_-Alkynic Fatty Acids
- Indonesian Medicinal Plants. XXV. Cancer Cell Invasion Inhibitory Effects of Chemical Constituents in the Parasitic Plant Scurrula atropurpurea (Loranthaceae)
- Composition of the endophytic filamentous fungi isolated from the tea plant Camellia sinensis
- Bisanthraquinone Metabolites Produced by the Endophytic Fungus Diaporthe sp.
- Stereoselective Oxidation at C-4 of Flavans by the Endophytic Fungus Diaporthe sp. Isolated from a Tea Plant
- Biooxidation of (+)-Catechin and (-)-Epicatechin into 3,4-Dihydroxyflavan Derivatives by the Endophytic Fungus Diaporthe sp. Isolated from a Tea Plant
- Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma
- Erythrocytosis caused by erythropoietin-producing thymic carcinoma
- Histological characteristics of 21 Papua New Guinean children with high-grade B-cell lymphoma, which is frequently associated with EBV infection
- Distribution of malignant lymphoma in Japan : Analysis of 2260 cases, 2001-2006
- Estimation of apoptosis and cell proliferation in histiocytic necrotizing lymphadenitis using immunohistochemical double staining
- Macrophages in Langerhans cell histiocytosis are differentiated toward M2 phenotype : Their possible involvement in pathological processes
- Indonesian Medicinal Plants. XXIII. Chemical Structured of Two New Migrated Pimarane-type Diterpenes, Neoorthosiphols A and B, and Suppressive Effects on Rat Thoracic Aorta of Chemical Constituents Isolated from the Leaves of Orthosiphon aristatus (Lamiac
- Vasodilator Stress Impairs the Left Ventricular Function Obtained With Gated Single-Photon Emission Computed Tomography in Patients With Known or Suspected Coronary Artery Disease
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Composition of endophytic fungi living in Cinchona ledgeriana (Rubiaceae)
- Artemisioside, a new monoterpene glucoside from the aerial parts of Artemisia ordosica (Asteraceae)
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Benzbromarone Pharmacokinetics and Pharmacodynamics in Different Cytochrome P450 2C9 Genotypes
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
- Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma
- Regression of rectal mucosa-associated lymphoid tissue (MALT) lymphoma after antibiotic treatments
- Infant juvenile myelomonocytic leukemia (JMML) with rapid infiltration of multiple organs
- Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T-cell lymphoma (AITL)
- Detection of HTLV-1 by means of HBZ gene in situ hybridization in formalin-fixed and paraffin-embedded tissues
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria : the AEGIS Clinical Trial
- Osteonecrosis of the humeral head
- M2 Macrophage/Microglial Cells Induce Activation of Stat3 in Primary Central Nervous System Lymphoma
- Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes